Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Iida

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Plos One|October 8, 2015
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ ReceptorsYuya Isoda, Hirokazu Yagi, Tadashi Satoh, et al.
Scientific Reports|October 25, 2017
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIaYoshitake Sakae, Tadashi Satoh, Hirokazu Yagi, et al.
Molecular Immunology|March 24, 2007
Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicityKazuhiro Masuda, Tsuguo Kubota, Etsuji Kaneko, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|October 26, 2011
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycansTsunehiro Mizushima, Hirokazu Yagi, Emi Takemoto, et al.
Plant & Cell Physiology|May 29, 2019
Generation of Yellow Flowers of the Japanese Morning Glory by Engineering Its Flavonoid Biosynthetic Pathway toward AuronesAtsushi Hoshino, Takayuki Mizuno, Keiichi Shimizu, et al.
Plant Biotechnology Journal|April 30, 2015
A petal-specific InMYB1 promoter from Japanese morning glory: a useful tool for molecular breeding of floricultural cropsMirai Azuma, Reina Morimoto, Mana Hirose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIaShigeru Iida, Hirofumi Misaka, Miho Inoue, et al.
Glycobiology|January 10, 2016
Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharidesTsuyoshi Yamada, Yutaka Kanda, Makoto Takayama, et al.
The Plant Journal : for Cell and Molecular Biology|April 22, 2005
Japanese morning glory dusky mutants displaying reddish-brown or purplish-gray flowers are deficient in a novel glycosylation enzyme for anthocyanin biosynthesis, UDP-glucose:anthocyanidin 3-O-glucoside-2''-O-glucosyltransferase, due to 4-bp insertions in the geneYasumasa Morita, Atsushi Hoshino, Yasumasa Kikuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patientsEiji Suzuki, Rinpei Niwa, Shigehira Saji, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Plos One|October 8, 2015
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ ReceptorsYuya Isoda, Hirokazu Yagi, Tadashi Satoh, et al.
Scientific Reports|October 25, 2017
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIaYoshitake Sakae, Tadashi Satoh, Hirokazu Yagi, et al.
Molecular Immunology|March 24, 2007
Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicityKazuhiro Masuda, Tsuguo Kubota, Etsuji Kaneko, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|October 26, 2011
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycansTsunehiro Mizushima, Hirokazu Yagi, Emi Takemoto, et al.
Plant & Cell Physiology|May 29, 2019
Generation of Yellow Flowers of the Japanese Morning Glory by Engineering Its Flavonoid Biosynthetic Pathway toward AuronesAtsushi Hoshino, Takayuki Mizuno, Keiichi Shimizu, et al.
Plant Biotechnology Journal|April 30, 2015
A petal-specific InMYB1 promoter from Japanese morning glory: a useful tool for molecular breeding of floricultural cropsMirai Azuma, Reina Morimoto, Mana Hirose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIaShigeru Iida, Hirofumi Misaka, Miho Inoue, et al.
Glycobiology|January 10, 2016
Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharidesTsuyoshi Yamada, Yutaka Kanda, Makoto Takayama, et al.
The Plant Journal : for Cell and Molecular Biology|April 22, 2005
Japanese morning glory dusky mutants displaying reddish-brown or purplish-gray flowers are deficient in a novel glycosylation enzyme for anthocyanin biosynthesis, UDP-glucose:anthocyanidin 3-O-glucoside-2''-O-glucosyltransferase, due to 4-bp insertions in the geneYasumasa Morita, Atsushi Hoshino, Yasumasa Kikuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patientsEiji Suzuki, Rinpei Niwa, Shigehira Saji, et al.
Pageof 8